• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响肺炎球菌病负担和对肺炎球菌疫苗免疫反应的环境因素:需要更明确的疫苗推荐。

Environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines: the need for more precisely delineated vaccine recommendations.

机构信息

a Pfizer Pharmaceuticals Korea Ltd ., Seoul , Republic of Korea.

b Division of Infectious Diseases, Department of Internal Medicine , Guro Hospital, Korea University College of Medicine , Seoul , Republic of Korea.

出版信息

Expert Rev Vaccines. 2019 Jun;18(6):587-596. doi: 10.1080/14760584.2019.1607303. Epub 2019 Apr 30.

DOI:10.1080/14760584.2019.1607303
PMID:30998430
Abstract

: Precision medicine describes the customization of healthcare tailored to the individual patient. Generally, vaccines are considered as public health tools rather than from the individual patient perspective. However, adult vaccination programs in particular should consider many different factors, at the individual level and also from societal, cultural and country-specific perspectives. Currently, most immunization programs, including those for pneumococcal vaccines, have only been adopted on the basis of age or medical risk. : Based on a broad literature search, this review addresses possible environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines. : Factors which influence the incidence of pneumococcal disease and the reaction against pneumococcal vaccination, including personal conditions, geographic/ethnic factors and social risks, are diverse. To maximize the effects of pneumococcal vaccination, not only for public health but also to induce optimal effects at the individual level, vaccines need to be verified under diverse situations and with collaboration among relevant medical societies, governments, and the pharmaceutical industry. Whereas vaccines are generally considered only from the public health perspective, flexible, comprehensive and tailored pneumococcal immunization programs, with appropriate policy support, can generate a greater positive impact on public health.

摘要

精准医学描述了根据个体患者量身定制的医疗保健。一般来说,疫苗被认为是公共卫生工具,而不是从个体患者的角度来看待。然而,成人疫苗接种计划尤其应该考虑许多不同的因素,包括个体层面以及社会、文化和国家特定的角度。目前,大多数免疫接种计划,包括肺炎球菌疫苗,仅基于年龄或医疗风险而被采用。

基于广泛的文献检索,本综述探讨了可能影响肺炎球菌疾病负担和对肺炎球菌疫苗免疫反应的环境因素。

影响肺炎球菌疾病发病率和肺炎球菌疫苗接种反应的因素包括个人状况、地理/种族因素和社会风险等,具有多样性。为了最大限度地发挥肺炎球菌疫苗的效果,不仅对公共卫生,而且对个体层面的最佳效果,疫苗需要在不同情况下进行验证,并在相关医学协会、政府和制药行业之间进行合作。虽然疫苗通常仅从公共卫生的角度考虑,但灵活、全面和量身定制的肺炎球菌免疫接种计划,在适当的政策支持下,可以对公共卫生产生更大的积极影响。

相似文献

1
Environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines: the need for more precisely delineated vaccine recommendations.影响肺炎球菌病负担和对肺炎球菌疫苗免疫反应的环境因素:需要更明确的疫苗推荐。
Expert Rev Vaccines. 2019 Jun;18(6):587-596. doi: 10.1080/14760584.2019.1607303. Epub 2019 Apr 30.
2
Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.克罗地亚肺炎球菌结合疫苗接种的成本效益
Vaccine. 2015 May 7;33 Suppl 1:A209-18. doi: 10.1016/j.vaccine.2014.12.043.
3
Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.肺炎球菌结合疫苗在慢性淋巴细胞白血病患者中引发的免疫应答优于肺炎球菌多糖疫苗:一项由瑞典 CLL 研究组开展的随机研究。
Vaccine. 2018 Jun 14;36(25):3701-3707. doi: 10.1016/j.vaccine.2018.05.012. Epub 2018 May 7.
4
Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.肺炎球菌多糖结合疫苗(与 CRM197 载体蛋白结合)在儿童和成人中的应用经验。
Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320.
5
Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.肺炎球菌多糖疫苗接种在成人中的应用:欧洲的新视角。
Expert Rev Vaccines. 2011 Aug;10(8):1143-67. doi: 10.1586/erv.11.99. Epub 2011 Aug 3.
6
Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).预防婴幼儿肺炎球菌病-使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗-免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18.
7
Streptococcus pneumoniae serotype 19A: worldwide epidemiology.19A 型肺炎链球菌:全球流行病学。
Expert Rev Vaccines. 2017 Oct;16(10):1007-1027. doi: 10.1080/14760584.2017.1362339. Epub 2017 Aug 28.
8
Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.PCV13 疫苗接种在比利时 65-84 岁高风险肺炎球菌感染成人中的成本效益。
PLoS One. 2018 Jul 6;13(7):e0199427. doi: 10.1371/journal.pone.0199427. eCollection 2018.
9
Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.肺炎球菌结合疫苗在 50 岁以下成人中预防肺炎球菌病的应用。
Expert Rev Vaccines. 2018 Jan;17(1):45-55. doi: 10.1080/14760584.2018.1411196. Epub 2017 Dec 6.
10
Cost-Effectiveness Analysis of Pneumococcal and Influenza Vaccines Administered to Children Less Than 5 Years of Age in a Low-Income District of Bogota, Colombia.哥伦比亚波哥大低收入地区5岁以下儿童接种肺炎球菌疫苗和流感疫苗的成本效益分析
Value Health Reg Issues. 2018 Dec;17:21-31. doi: 10.1016/j.vhri.2018.01.001. Epub 2018 Apr 5.

引用本文的文献

1
Pneumococcal vaccines in China.中国的肺炎球菌疫苗
Hum Vaccin Immunother. 2025 Dec;21(1):2460274. doi: 10.1080/21645515.2025.2460274. Epub 2025 Jan 30.
2
Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to Go.影响微生物群调节疫苗免疫反应的因素:任重道远。
Vaccines (Basel). 2023 Oct 18;11(10):1609. doi: 10.3390/vaccines11101609.
3
The remarkable history of pneumococcal vaccination: an ongoing challenge.肺炎球菌疫苗的非凡历史:一项持续的挑战。
Pneumonia (Nathan). 2022 Sep 25;14(1):5. doi: 10.1186/s41479-022-00097-y.
4
Pollution, Inflammation, and Vaccines: A Complex Crosstalk.污染、炎症与疫苗:复杂的相互作用
Int J Environ Res Public Health. 2021 Jun 11;18(12):6330. doi: 10.3390/ijerph18126330.
5
Recent advances in the epidemiology and prevention of infections.感染病流行病学与预防的最新进展。
F1000Res. 2020 May 7;9. doi: 10.12688/f1000research.22341.1. eCollection 2020.